Global Bacteriophages (Phage) Products Market Growth 2025-2031
The global Bacteriophages (Phage) Products market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection.
United States market for Bacteriophages (Phage) Products is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Bacteriophages (Phage) Products is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Bacteriophages (Phage) Products is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Bacteriophages (Phage) Products players cover Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the ?Bacteriophages (Phage) Products Industry Forecast? looks at past sales and reviews total world Bacteriophages (Phage) Products sales in 2024, providing a comprehensive analysis by region and market sector of projected Bacteriophages (Phage) Products sales for 2025 through 2031. With Bacteriophages (Phage) Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bacteriophages (Phage) Products industry.
This Insight Report provides a comprehensive analysis of the global Bacteriophages (Phage) Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bacteriophages (Phage) Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Bacteriophages (Phage) Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bacteriophages (Phage) Products and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bacteriophages (Phage) Products.
This report presents a comprehensive overview, market shares, and growth opportunities of Bacteriophages (Phage) Products market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
DsDNA Type
SsDNA Type
SsRNA Type
Others
Segmentation by Application:
Animal Health
Aquaculture
Agriculture
Food Industry
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bacteriophages (Phage) Products market?
What factors are driving Bacteriophages (Phage) Products market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bacteriophages (Phage) Products market opportunities vary by end market size?
How does Bacteriophages (Phage) Products break out by Type, by Application?
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection.
United States market for Bacteriophages (Phage) Products is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Bacteriophages (Phage) Products is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Bacteriophages (Phage) Products is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Bacteriophages (Phage) Products players cover Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the ?Bacteriophages (Phage) Products Industry Forecast? looks at past sales and reviews total world Bacteriophages (Phage) Products sales in 2024, providing a comprehensive analysis by region and market sector of projected Bacteriophages (Phage) Products sales for 2025 through 2031. With Bacteriophages (Phage) Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bacteriophages (Phage) Products industry.
This Insight Report provides a comprehensive analysis of the global Bacteriophages (Phage) Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bacteriophages (Phage) Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Bacteriophages (Phage) Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bacteriophages (Phage) Products and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bacteriophages (Phage) Products.
This report presents a comprehensive overview, market shares, and growth opportunities of Bacteriophages (Phage) Products market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
DsDNA Type
SsDNA Type
SsRNA Type
Others
Segmentation by Application:
Animal Health
Aquaculture
Agriculture
Food Industry
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bacteriophages (Phage) Products market?
What factors are driving Bacteriophages (Phage) Products market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bacteriophages (Phage) Products market opportunities vary by end market size?
How does Bacteriophages (Phage) Products break out by Type, by Application?
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
